Trial Profile
Safety and efficacy study of bivalirudin during percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary) ; Heparin
- Indications Acute coronary syndromes; Thrombosis
- Focus Adverse reactions; Therapeutic Use
- 03 Dec 2015 New trial record